Literature DB >> 12920588

Esophageal cancer in Germany is associated with Epstein-Barr-virus but not with papillomaviruses.

S Awerkiew1, E Bollschweiler, R Metzger, P M Schneider, A H Hölscher, H Pfister.   

Abstract

Esophageal squamous cell carcinomas ( n=23) and adenocarcinomas ( n=14) from German patients were tested for the presence of human papillomavirus (HPV) and Epstein-Barr-Virus (EBV) DNA. No DNA for either genital HPV or epidermodysplasia verruciformis-associated HPV was detected in any tumor. In contrast, 35% of squamous cell carcinomas and 36% of adenocarcinomas were shown to contain EBV DNA by nested polymerase chain reaction.

Entities:  

Mesh:

Year:  2002        PMID: 12920588     DOI: 10.1007/s00430-002-0128-z

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  42 in total

1.  Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ.

Authors:  U Wieland; S Jurk; S Weissenborn; T Krieg; H Pfister; A Ritzkowsky
Journal:  J Invest Dermatol       Date:  2000-09       Impact factor: 8.551

2.  Human papillomavirus type 16 DNA in esophageal carcinomas from Alaska Natives.

Authors:  B A Miller; M Davidson; D Myerson; J Icenogle; A P Lanier; J Tan; A M Beckmann
Journal:  Int J Cancer       Date:  1997-04-10       Impact factor: 7.396

3.  Human papillomaviruses.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risks Hum       Date:  1995

4.  Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas.

Authors:  J P Klussmann; S J Weissenborn; U Wieland; V Dries; J Kolligs; M Jungehuelsing; H E Eckel; H P Dienes; H J Pfister; P G Fuchs
Journal:  Cancer       Date:  2001-12-01       Impact factor: 6.860

5.  Inverse association between intake of cereal fiber and risk of gastric cardia cancer.

Authors:  P Terry; J Lagergren; W Ye; A Wolk; O Nyrén
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

6.  Evaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor posttransplant lymphoproliferative disease.

Authors:  Barbara C Gärtner; Hansjörg Schäfer; Katja Marggraff; Günter Eisele; Marco Schäfer; Dagmar Dilloo; Klaus Roemer; Hans-Jürgen Laws; Martina Sester; Urban Sester; Hermann Einsele; Nikolaus Mueller-Lantzsch
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

7.  Association between body mass and adenocarcinoma of the esophagus and gastric cardia.

Authors:  J Lagergren; R Bergström; O Nyrén
Journal:  Ann Intern Med       Date:  1999-06-01       Impact factor: 25.391

8.  Human papillomavirus infection and esophageal cancer: a nationwide seroepidemiologic case-control study in Sweden.

Authors:  J Lagergren; Z Wang; R Bergström; J Dillner; O Nyrén
Journal:  J Natl Cancer Inst       Date:  1999-01-20       Impact factor: 13.506

9.  Infection of human papillomavirus (HPV) and Epstein-Barr virus (EBV) and p53 expression in human esophageal carcinoma.

Authors:  A Khurshid; N Kazuya; I Hanae; I Manabu
Journal:  J Pak Med Assoc       Date:  1998-05       Impact factor: 0.781

10.  Absence of human papillomavirus DNA from esophageal carcinoma as determined by multiple broad spectrum polymerase chain reactions.

Authors:  H L Smits; S P Tjong-A-Hung; J ter Schegget; K Nooter; T Kok
Journal:  J Med Virol       Date:  1995-07       Impact factor: 2.327

View more
  15 in total

Review 1.  Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers.

Authors:  Ioannis N Mammas; George Sourvinos; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2010-07-18       Impact factor: 3.201

2.  Presence of Epstein-Barr virus in esophageal cancer is restricted to tumor infiltrating lymphocytes.

Authors:  Sabine Awerkiew; Axel zur Hausen; Stephan E Baldus; Arnulf H Hölscher; Svetlana I Sidorenko; Sergej I Kutsev; Herbert J Pfister
Journal:  Med Microbiol Immunol       Date:  2005-02-04       Impact factor: 3.402

3.  The absence of human papillomavirus in esophageal squamous cell carcinoma in East China.

Authors:  Haohua Teng; Xiaojing Li; Xiuping Liu; Jie Wu; Jie Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

Review 4.  Regulation of apoptosis by the papillomavirus E6 oncogene.

Authors:  Ting-Ting Li; Li-Na Zhao; Zhi-Guo Liu; Ying Han; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

5.  Incidence of human papilloma virus in esophageal squamous cell carcinoma in patients from the Lublin region.

Authors:  Andrzej Dąbrowski; Wojciech Kwaśniewski; Tomasz Skoczylas; Wiesława Bednarek; Dorota Kuźma; Anna Goździcka-Józefiak
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

Review 6.  Viruses, Other Pathogenic Microorganisms and Esophageal Cancer.

Authors:  Wenji Xu; Zhongshu Liu; Quncha Bao; Zhikan Qian
Journal:  Gastrointest Tumors       Date:  2015-04-08

7.  Retracted: Increased risk of stomach and esophageal malignancies in people with AIDS.

Authors:  E Christina Persson; Meredith S Shiels; Sanford M Dawsey; Kishor Bhatia; Lesley A Anderson; Eric A Engels
Journal:  Gastroenterology       Date:  2012-07-14       Impact factor: 22.682

8.  The role of inflammation in HPV infection of the Oesophagus.

Authors:  Georgia Schäfer; Siti Kabanda; Beverly van Rooyen; Martina Bergant Marušič; Lawrence Banks; M Iqbal Parker
Journal:  BMC Cancer       Date:  2013-04-09       Impact factor: 4.430

Review 9.  Association between human papillomavirus (HPV) and oesophageal squamous cell carcinoma: a meta-analysis.

Authors:  H A Hardefeldt; M R Cox; G D Eslick
Journal:  Epidemiol Infect       Date:  2014-06       Impact factor: 4.434

10.  Epstein-Barr Virus encoded LMP1 regulates cyclin D1 promoter activity by nuclear EGFR and STAT3 in CNE1 cells.

Authors:  Yang Xu; Ying Shi; Qi Yuan; Xuli Liu; Bin Yan; Ling Chen; Yongguang Tao; Ya Cao
Journal:  J Exp Clin Cancer Res       Date:  2013-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.